Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?

Ann Oncol. 2000 Jan;11(1):117-8. doi: 10.1023/a:1008364801718.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Cisplatin / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Incidence
  • Infusions, Intravenous
  • Middle Aged
  • Retrospective Studies
  • Thromboembolism / chemically induced*
  • Thromboembolism / prevention & control
  • Venous Thrombosis / chemically induced*
  • Venous Thrombosis / prevention & control
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives
  • Vinorelbine

Substances

  • Antineoplastic Agents, Phytogenic
  • Vinblastine
  • Cisplatin
  • Vinorelbine
  • Fluorouracil

Supplementary concepts

  • ViFuP protocol